James Zimring, MD, PhD
The Association for the Advancement of Blood and Biotherapies (AABB) has selected James Zimring, MD, PhD, as the recipient of the 2024 Tibor Greenwalt Memorial Award and Lectureship. Dr. Zimring is the Thomas W. Tillack Professor of Experimental Pathology in the Department of Pathology and Laboratory Medicine. Established in 2006 through a grant from Peter Greenwalt, MD, this award recognizes an individual who has made major scientific or clinical contributions to hematology, transfusion medicine or biotherapies, and succinctly communicated these advances.
Dr. Zimring’s contributions to the field of pathology and transfusion medicine and his scientific achievements are commendable. He was among the first to use murine models extensively to study transfusion-based alloimmunization to red blood cells, hemolytic transfusion reactions and mechanisms of immunoprophylaxis of anti-D. These models have since been used throughout the field and have been indispensable in spurring further developments and leading to improvements in blood safety worldwide.
Dr. Zimring will be recognized at the AABB Annual Meeting in Houston, Texas on October 19-22, and will also present a lecture.
The AABB is a top international transfusion society with representation in more than 80 countries. The Association fosters advancements in the field of transfusion medicine through the delivery of standards, accreditation and educational programs that focus on optimizing patient and donor care and safety.
Filed Under: Honors & Awards